Methods and compositions for inhibition of innate immune responses and autoimmunity

Details for Australian Patent Application No. 2012203156 (hide)

Owner Dynavax Technologies Corporation

Inventors Barrat, Franck; Coffman, Robert L.

Agent Davies Collison Cave

Pub. Number AU-B-2012203156

Parent 2005282889

Filing date 29 May 2012

Wipo publication date 21 June 2012

Acceptance publication date 20 September 2012

International Classifications

C07H 21/00 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

A61K 31/7088 - Compounds having three or more nucleosides or nucleotides

A61K 31/7115 - Nucleic acids or oligonucleotides having modified bases, i.e. other than adenine, guanine, cytosine, uracil or thymine

Event Publications

14 June 2012 Complete Application Filed

21 June 2012 Application Open to Public Inspection

  Published as AU-B-2012203156

20 September 2012 Application Accepted

  Published as AU-B-2012203156

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012203157-Anti-theft device

2012203155-Process for preparing 5-biphenyl-4-amino-2-methyl pentanoic acid